These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 16714840)
1. Relationship between the serum concentrations of C-reactive protein and parameters of adiposity and insulin resistance in patients with type 2 diabetes mellitus. Iwasaki T; Nakajima A; Yoneda M; Terauchi Y Endocr J; 2006 Jun; 53(3):345-56. PubMed ID: 16714840 [TBL] [Abstract][Full Text] [Related]
2. Serum butyrylcholinesterase is strongly associated with adiposity, the serum lipid profile and insulin resistance. Iwasaki T; Yoneda M; Nakajima A; Terauchi Y Intern Med; 2007; 46(19):1633-9. PubMed ID: 17917325 [TBL] [Abstract][Full Text] [Related]
3. Serum ferritin is associated with visceral fat area and subcutaneous fat area. Iwasaki T; Nakajima A; Yoneda M; Yamada Y; Mukasa K; Fujita K; Fujisawa N; Wada K; Terauchi Y Diabetes Care; 2005 Oct; 28(10):2486-91. PubMed ID: 16186284 [TBL] [Abstract][Full Text] [Related]
4. Relationship of regional adiposity to insulin resistance and serum triglyceride levels in nonobese Japanese type 2 diabetic patients. Taniguchi A; Nakai Y; Sakai M; Yoshii S; Hamanaka D; Hatae Y; Kawata M; Yamanouchi K; Okumura T; Doi K; Tokuyama K; Nagasaka S; Fukushima M Metabolism; 2002 May; 51(5):544-8. PubMed ID: 11979383 [TBL] [Abstract][Full Text] [Related]
5. Visceral adiposity and leptin are independently associated with C-reactive protein in Korean type 2 diabetic patients. Park JS; Cho MH; Nam JS; Ahn CW; Cha BS; Lee EJ; Lim SK; Kim KR; Lee HC Acta Diabetol; 2010 Jun; 47(2):113-8. PubMed ID: 19415164 [TBL] [Abstract][Full Text] [Related]
6. Effects of liraglutide, a human glucagon-like peptide-1 analogue, on body weight, body fat area and body fat-related markers in patients with type 2 diabetes mellitus. Suzuki D; Toyoda M; Kimura M; Miyauchi M; Yamamoto N; Sato H; Tanaka E; Kuriyama Y; Miyatake H; Abe M; Umezono T; Fukagawa M Intern Med; 2013; 52(10):1029-34. PubMed ID: 23676586 [TBL] [Abstract][Full Text] [Related]
7. Visceral adiposity and inflammatory bowel disease. Rowan CR; McManus J; Boland K; O'Toole A Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989 [TBL] [Abstract][Full Text] [Related]
8. Relationship between abdominal fat accumulation and insulin resistance in hemodialysis patients. Gohda T; Gotoh H; Tanimoto M; Sato M; Io H; Kaneko K; Hamada C; Tomino Y Hypertens Res; 2008 Jan; 31(1):83-8. PubMed ID: 18360022 [TBL] [Abstract][Full Text] [Related]
9. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Yatagai T; Nagasaka S; Taniguchi A; Fukushima M; Nakamura T; Kuroe A; Nakai Y; Ishibashi S Metabolism; 2003 Oct; 52(10):1274-8. PubMed ID: 14564678 [TBL] [Abstract][Full Text] [Related]
10. High visceral fat with low subcutaneous fat accumulation as a determinant of atherosclerosis in patients with type 2 diabetes. Bouchi R; Takeuchi T; Akihisa M; Ohara N; Nakano Y; Nishitani R; Murakami M; Fukuda T; Fujita M; Minami I; Izumiyama H; Hashimoto K; Yoshimoto T; Ogawa Y Cardiovasc Diabetol; 2015 Oct; 14():136. PubMed ID: 26445876 [TBL] [Abstract][Full Text] [Related]
11. Serum Cystatin C levels increase with increasing visceral fat area in patients with type 2 diabetes mellitus. Cong X; Chen X; Shen Q; Wu Y; Wang Q; Chen L Sci Rep; 2024 Aug; 14(1):18638. PubMed ID: 39128944 [TBL] [Abstract][Full Text] [Related]
12. Impact of visceral fat on gene expression profile in peripheral blood cells in obese Japanese subjects. Obata Y; Maeda N; Yamada Y; Yamamoto K; Nakamura S; Yamaoka M; Tanaka Y; Masuda S; Nagao H; Fukuda S; Fujishima Y; Kita S; Nishizawa H; Funahashi T; Matsubara KI; Matsuzawa Y; Shimomura I Cardiovasc Diabetol; 2016 Nov; 15(1):159. PubMed ID: 27899146 [TBL] [Abstract][Full Text] [Related]
13. Effects of Aging on Visceral and Subcutaneous Fat Areas and on Homeostasis Model Assessment of Insulin Resistance and Insulin Secretion Capacity in a Comprehensive Health Checkup. Hirose H; Takayama M; Iwao Y; Kawabe H J Atheroscler Thromb; 2016; 23(2):207-15. PubMed ID: 26412583 [TBL] [Abstract][Full Text] [Related]
14. Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy. Putz DM; Goldner WS; Bar RS; Haynes WG; Sivitz WI Metabolism; 2004 Nov; 53(11):1454-61. PubMed ID: 15536601 [TBL] [Abstract][Full Text] [Related]
15. Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type. Miyazaki Y; DeFronzo RA Cardiovasc Diabetol; 2009 Aug; 8():44. PubMed ID: 19656356 [TBL] [Abstract][Full Text] [Related]
16. Association of subcutaneous and visceral fat mass with serum concentrations of adipokines in subjects with type 2 diabetes mellitus. Saito T; Murata M; Otani T; Tamemoto H; Kawakami M; Ishikawa SE Endocr J; 2012; 59(1):39-45. PubMed ID: 22019947 [TBL] [Abstract][Full Text] [Related]
17. High serum levels of C-reactive protein (CRP) predict beneficial decrease of visceral fat in obese females after sleeve gastrectomy. Carbone F; Nulli Migliola E; Bonaventura A; Vecchié A; De Vuono S; Ricci MA; Vaudo G; Boni M; Dallegri F; Montecucco F; Lupattelli G Nutr Metab Cardiovasc Dis; 2018 May; 28(5):494-500. PubMed ID: 29502925 [TBL] [Abstract][Full Text] [Related]
18. Associations of visceral adiposity and exercise participation with C-reactive protein, insulin resistance, and endothelial dysfunction in Korean healthy adults. Kim K; Valentine RJ; Shin Y; Gong K Metabolism; 2008 Sep; 57(9):1181-9. PubMed ID: 18702942 [TBL] [Abstract][Full Text] [Related]
19. Comparison of Computed Tomography-based Abdominal Adiposity Indexes as Predictors of Non-alcoholic Fatty Liver Disease Among Middle-aged Korean Men and Women. Baek J; Jung SJ; Shim JS; Jeon YW; Seo E; Kim HC J Prev Med Public Health; 2020 Jul; 53(4):256-265. PubMed ID: 32752595 [TBL] [Abstract][Full Text] [Related]
20. Relationships between Composition of Major Fatty Acids and Fat Distribution and Insulin Resistance in Japanese. Fujii C; Kawai T; Azuma K; Oguma Y; Katsukawa F; Hirose H; Tanaka K; Meguro S; Matsumoto H; Itoh H J Diabetes Res; 2017; 2017():1567467. PubMed ID: 28540308 [No Abstract] [Full Text] [Related] [Next] [New Search]